HomeHealthDaily pill daraxonrasib doubles survival time for pancreatic cancer patients

Daily pill daraxonrasib doubles survival time for pancreatic cancer patients



The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments